Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Cetilistat impurity 1
Cat. No.:
OB0425LY-114
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
Cetilistat impurity 1 is a lipase inhibitor that effectively reduces fat absorption, thereby helping to reduce weight.
Synonyms:
890655-08-0; 2-(Hexadecoxycarbonylamino)-5-methylbenzoic acid; 2-(((Hexadecyloxy)carbonyl)amino)-5-methylbenzoic acid
CAS No.:
890655-08-0
Compound CID:
11697437
Formula:
C25H41NO4
Formula Weight:
419.6
Specification
Target:
Drug metabolite
Pathway:
Metabolic enzyme/Protease
Storage:
Storage at -20°C.
Applications:
Cetilistat impurity 1 is primarily used in drug discovery and quality control studies to ensure the purity and efficacy of Cetilistat.
